These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29733015)

  • 1. Transoral Incisionless Fundoplication (TIF 2.0): A Meta-Analysis of Three Randomized, Controlled Clinical Trials.
    Gerson L; Stouch B; Lobonţiu A
    Chirurgia (Bucur); 2018; 113(2):173-184. PubMed ID: 29733015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
    Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
    Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis.
    Huang X; Chen S; Zhao H; Zeng X; Lian J; Tseng Y; Chen J
    Surg Endosc; 2017 Mar; 31(3):1032-1044. PubMed ID: 27495332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.
    Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM
    J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
    McCarty TR; Itidiare M; Njei B; Rustagi T
    Endoscopy; 2018 Jul; 50(7):708-725. PubMed ID: 29625507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
    Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
    Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature.
    Wendling MR; Melvin WS; Perry KA
    Surg Endosc; 2013 Oct; 27(10):3754-61. PubMed ID: 23644835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.
    Chimukangara M; Jalilvand AD; Melvin WS; Perry KA
    Surg Endosc; 2019 Apr; 33(4):1304-1309. PubMed ID: 30167944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
    Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
    Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year results of a multicenter prospective study of transoral incisionless fundoplication.
    Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G
    Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.
    Testoni PA; Corsetti M; Di Pietro S; Castellaneta AG; Vailati C; Masci E; Passaretti S
    World J Surg; 2010 Apr; 34(4):750-7. PubMed ID: 20091308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
    Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
    Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of different endoscopic treatments for gastroesophageal reflux disease: a systematic review and network meta-analysis.
    Yao L; Lin Y; He X; Liu G; Wang B; Wang W; Li D
    J Gastrointest Surg; 2024 Jul; 28(7):1051-1061. PubMed ID: 38670431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease.
    Ihde GM; Besancon K; Deljkich E
    Am J Surg; 2011 Dec; 202(6):740-6; discussion 746-7. PubMed ID: 22014853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience.
    Wilson EB; Barnes WE; Mavrelis PG; Carter BJ; Bell RC; Sewell RW; Ihde GM; Dargis D; Hoddinott KM; Shughoury AB; Gill BD; Fox MA; Turgeon DG; Freeman KD; Gunsberger T; Hausmann MG; Leblanc KA; Deljkich E; Trad KS
    Surg Laparosc Endosc Percutan Tech; 2014 Feb; 24(1):36-46. PubMed ID: 24487156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of Laryngopharyngeal Symptoms to Transoral Incisionless Fundoplication in Patients with Refractory Proven Gastroesophageal Reflux.
    Snow GE; Dbouk M; Akst LM; Ihde G; Zarnegar R; Janu P; Murray M; Eskarous H; Sohagia A; Dhar SI; Irene Canto M
    Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):662-670. PubMed ID: 34378427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
    Testoni PA; Vailati C; Testoni S; Corsetti M
    Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.